We are live on ! Find out more
ORGS

Orgenesis Inc. Common Stock

Delisted

ORGS was delisted on the 18th of October, 2024.

40 hedge funds and large institutions have $27.5M invested in Orgenesis Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 3

167% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 3

150% more funds holding

Funds holding: 1640 (+24)

138% more capital invested

Capital invested by funds: $11.6M → $27.5M (+$15.9M)

4.01% more ownership

Funds ownership: 16.72%20.73% (+4%)

Holders
40
Holders Change
+24
Holders Change %
+150%
% of All Funds
0.82%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
27
Increased
8
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change

ORGS Hedge Fund Activity: Q2 2020 in Review

40 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q2 2020, worth a combined $27.5M — up 138% from $11.6M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new ORGS positions and 3 closed out — a net gain of 24 holders — while 8 added to existing stakes and 3 trimmed.

The largest buyer was BlackRock, adding an estimated $5.02M. The largest seller was Sphera Funds Management, cutting an estimated $2.69M.

  • 40 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q2 2020, up from 16 in Q1 2020.
  • Funds reported $27.5M of Orgenesis Inc. Common Stock stock for Q2 2020, up 138% quarter-over-quarter.
  • 27 funds opened new Orgenesis Inc. Common Stock positions in Q2 2020 and 3 closed out, a net change of +24 holders.
  • The largest Orgenesis Inc. Common Stock buyer in Q2 2020 was BlackRock, an estimated $5.02M added.
  • The largest Orgenesis Inc. Common Stock seller in Q2 2020 was Sphera Funds Management, an estimated $2.69M sold.

Based on aggregated 13F filings for Q2 2020.